- Home
- OMCL vs PCT Comparison
OMCL vs PCT Comparison
Compare OMCL & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCL
- PCT
- Stock Information
- Founded
- OMCL 1992
- PCT 2015
- Country
- OMCL United States
- PCT United States
- Employees
- OMCL N/A
- PCT N/A
- Industry
- OMCL Computer Manufacturing
- PCT Environmental Services
- Sector
- OMCL Technology
- PCT Utilities
- Exchange
- OMCL Nasdaq
- PCT Nasdaq
- Market Cap
- OMCL 1.3B
- PCT 2.5B
- IPO Year
- OMCL 2001
- PCT N/A
- Fundamental
- Price
- OMCL $28.69
- PCT $15.28
- Analyst Decision
- OMCL Buy
- PCT Strong Buy
- Analyst Count
- OMCL 6
- PCT 4
- Target Price
- OMCL $44.83
- PCT $13.00
- AVG Volume (30 Days)
- OMCL 415.8K
- PCT 5.0M
- Earning Date
- OMCL 07-31-2025
- PCT 08-07-2025
- Dividend Yield
- OMCL N/A
- PCT N/A
- EPS Growth
- OMCL N/A
- PCT N/A
- EPS
- OMCL 0.45
- PCT N/A
- Revenue
- OMCL $1,135,755,000.00
- PCT $1,580,000.00
- Revenue This Year
- OMCL $3.84
- PCT $99.94
- Revenue Next Year
- OMCL $3.98
- PCT N/A
- P/E Ratio
- OMCL $63.65
- PCT N/A
- Revenue Growth
- OMCL 3.00
- PCT N/A
- 52 Week Low
- OMCL $22.66
- PCT $4.50
- 52 Week High
- OMCL $55.75
- PCT $15.98
- Technical
- Relative Strength Index (RSI)
- OMCL 43.98
- PCT 72.20
- Support Level
- OMCL $28.81
- PCT $13.42
- Resistance Level
- OMCL $30.19
- PCT $15.98
- Average True Range (ATR)
- OMCL 0.88
- PCT 0.74
- MACD
- OMCL 0.02
- PCT 0.03
- Stochastic Oscillator
- OMCL 34.49
- PCT 80.56
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
About PCT PureCycle Technologies Inc. Common stock
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.